Oncology
Rita Fior’s clinical research activity is centered on oncology, with a focus on breast cancer and ovarian cancer. The sponsor is involved in studies addressing advanced and recurrent disease settings, including metastatic breast cancer and relapsed ovarian cancer.
- Breast cancer
- Ovarian cancer
- Metastatic disease
- Relapsed cancer
The therapeutic interest extends to treatment selection in patients with malignant pleural effusion and/or ascites, reflecting a clinical focus on difficult-to-manage manifestations of advanced malignancy.
Predictive Treatment Guidance
The sponsor supports research into predictive models for treatment efficacy, with an emphasis on guiding therapeutic decisions in ovarian cancer and metastatic breast cancer. This area of interest includes evaluation of tools intended to support individualized oncology care.
- Predictive testing
- Treatment efficacy
- Therapeutic decision-making
- Individualized oncology care
Research activity in this domain is directed toward comparing test-guided treatment selection with standard clinical choice in patients with advanced cancer.
